We are live on ! Find out more
SGRY icon

Surgery Partners

138 hedge funds and large institutions have $2.19B invested in Surgery Partners in 2022 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 33 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 33

62% more call options, than puts

Call options by funds: $9.57M | Put options by funds: $5.89M

1.67% more ownership

Funds ownership: 102.75%104.42% (+1.7%)

5% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 22

1% more funds holding

Funds holding: 137138 (+1)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

18% less capital invested

Capital invested by funds: $2.66B → $2.19B (-$472M)

Holders
138
Holders Change
+1
Holders Change %
+0.73%
% of All Funds
2.38%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
23
Increased
58
Reduced
33
Closed
22
Calls
$9.57M
Puts
$5.89M
Net Calls
+$3.68M
Net Calls Change
+$3.17M
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$7.03M -$1.17M -36,706 -11%
Charles Schwab
27
Charles Schwab
California
$6.65M +$647K +20,269 +8%
APM
28
Avidity Partners Management
Texas
$6.26M +$8.55M +267,600 New
PC
29
Pier Capital
Connecticut
$5.59M +$1.47M +46,047 +24%
Goldman Sachs
30
Goldman Sachs
New York
$5.15M +$4.63M +145,096 +194%
Morgan Stanley
31
Morgan Stanley
New York
$4.6M +$79.9K +2,503 +1%
SBH
32
Segall Bryant & Hamill
Illinois
$4.2M +$114K +3,574 +2%
RCW
33
Rheos Capital Works
Japan
$4.09M
Federated Hermes
34
Federated Hermes
Pennsylvania
$3.85M -$11.2M -349,794 -68%
DCM
35
Dimension Capital Management
Florida
$3.77M
Bank of New York Mellon
36
Bank of New York Mellon
New York
$3.76M +$500K +15,653 +11%
Citadel Advisors
37
Citadel Advisors
Florida
$3.44M +$2.88M +90,248 +159%
SGH
38
Sivik Global Healthcare
Connecticut
$3.24M +$2.03M +63,509 +85%
First Eagle Investment Management
39
First Eagle Investment Management
New York
$3.09M +$1.47M +45,963 +53%
CSS
40
Cubist Systematic Strategies
Connecticut
$2.74M +$201K +6,307 +6%
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$2.6M -$75.7K -2,370 -2%
ECM
42
ExodusPoint Capital Management
New York
$2.29M +$3.12M +97,851 New
Swiss National Bank
43
Swiss National Bank
Switzerland
$2.24M +$38.3K +1,200 +1%
Man Group
44
Man Group
United Kingdom
$2.24M +$3.06M +95,759 New
Millennium Management
45
Millennium Management
New York
$2.15M -$1.63M -50,967 -36%
TD Asset Management
46
TD Asset Management
Ontario, Canada
$1.75M -$762K -23,876 -25%
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$1.57M +$978K +30,617 +84%
KCM
48
Kennedy Capital Management
Missouri
$1.52M +$1.12K +35 +0.1%
WMSA
49
Weiss Multi-Strategy Advisers
New York
$1.46M +$844K +26,445 +74%
JP Morgan Chase
50
JP Morgan Chase
New York
$1.4M +$205K +6,429 +12%

SGRY Hedge Fund Activity: Q3 2022 in Review

138 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q3 2022, worth a combined $2.19B — down 18% from $2.66B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new SGRY positions and 22 closed out — a net gain of 1 holder — while 58 added to existing stakes and 33 trimmed.

The largest buyer was Cannell & Co, adding an estimated $17M. The largest seller was T. Rowe Price Associates, cutting an estimated $49.5M.

  • 138 institutional investors held Surgery Partners (SGRY) as of Q3 2022, up from 137 in Q2 2022.
  • Funds reported $2.19B of Surgery Partners stock for Q3 2022, down 18% quarter-over-quarter.
  • 23 funds opened new Surgery Partners positions in Q3 2022 and 22 closed out, a net change of +1 holder.
  • The largest Surgery Partners buyer in Q3 2022 was Cannell & Co, an estimated $17M added.
  • The largest Surgery Partners seller in Q3 2022 was T. Rowe Price Associates, an estimated $49.5M sold.

Based on aggregated 13F filings for Q3 2022.